Tag Archives: Dr Oystein Fluge

Searching for serum antibodies to neuronal proteins in patients with ME/CFS

Posted on May 29, 2019 by wames

Searching for serum antibodies to neuronal proteins in patients with Myalgic Encephalopathy/Chronic Fatigue Syndrome, by Maria Pia Giannoccaro, Judith Cossins, Kari Sorland, Oystein Fluge, Angela Vincent in Clinical Therapeutics Vol 41, Issue 5, May 2019, Pages 836-847   Research abstract: Purpose: … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Searching for serum antibodies to neuronal proteins in patients with ME/CFS

B-Lymphocyte depletion in patients with ME/CFS: the final rituximab trial results

Posted on April 3, 2019 by wames

B-lymphocyte depletion in patients With Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: a randomized, double-blind, placebo-controlled trial by Oystein Fluge, Ingrid G. Rekeland, Katarina Lien, Hanne Thurmer, Petter C. Borchgrevink, Christoph Schafer, Kari Sorland, Jorg Assmus, Irini Ktoridou-Valen, Ingrid Herder, Merethe E. … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on B-Lymphocyte depletion in patients with ME/CFS: the final rituximab trial results

Immunosignature analysis of ME/CFS – promising diagnostic biomarker

Posted on October 15, 2018 by wames

Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Oliver P Günther, Jennifer L Gardy, Phillip Stafford, Øystein Fluge, Olav Mella, Patrick Tang, Ruth R Miller, Shoshana M Parker, Stephen A Johnston, David M Patrick in Molecular Neurobiology (2018) pp 1-9 [Published online: … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , | Comments Off on Immunosignature analysis of ME/CFS – promising diagnostic biomarker

Norwegian rituximab trial reports negative results

Posted on November 28, 2017 by wames

The Norwegian Rituximab trial reports negative results ahead of the publication of the full results. Attempts are now under way to determine the best way forward in understanding what has been learned and how to find out which patients may still benefit from … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Norwegian rituximab trial reports negative results

Norwegian Rituximab studies update

Posted on November 3, 2017 by wames

Helse Bergen blog post, 29 Sep 29017: RituxME B-lymphocyte depletion using the anti-CD20 antibody rituximab (Mabthera®) in Myalgic Encephalopathy/Chronic Fatigue Syndrome (“RituxME”) ​RituxME is a multicentre study conducted in five study centres in Norway: the Oncology Department at Haukeland University … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Norwegian Rituximab studies update

Metabolic switch may bring on CFS

Posted on February 14, 2017 by wames

New Scientist article, by Andy Coghlan, 13 February 2016: Metabolic switch may bring on chronic fatigue syndrome It’s as if a switch has been flicked. Evidence is mounting that chronic fatigue syndrome (CFS) is caused by the body swapping to … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Metabolic switch may bring on CFS

Video lectures from English & Norwegian researchers in Norwich

Posted on February 10, 2017 by wames

Invest in ME public talks in Norwich on ME/CFS biomedical research, published 7 Feb 2017 An event held in Norwich in January 2017 gave the public a chance to hear about some of the biomedical research being undertaken on the … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Video lectures from English & Norwegian researchers in Norwich

UK Rituximab trial collaboration between Norway & UK featured on BBC

Posted on January 27, 2017 by wames

BBC Look East video clip, 26 January 2017: Research in Norwich could offer ME/CFS breakthrough  Researchers in Norwich are teaming up with researchers from Norway to collaborate on ME/CFS research. The researchers say they believe that ME is reversible, and … Continue reading →

Posted in News | Tagged , , , , , , , | Comments Off on UK Rituximab trial collaboration between Norway & UK featured on BBC

Discussion of Fluge’s finding of key metabolic enzyme impairment in ME/CFS

Posted on January 18, 2017 by wames

TV2 interview with Dr Øystein Fluge on his latest research on ME/CFS – in Norwegian with English subtitles. Begins with a man who is very severely affected by ME. (11 minutes 23 seconds)    Watch video   Medscape Medical news article, 13 January 2017: … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Discussion of Fluge’s finding of key metabolic enzyme impairment in ME/CFS

Fuel shortage: Norwegian study expands on energy problem in ME/CFS

Posted on January 9, 2017 by wames

Health rising blog post, by Cort Johnson, 27 Dec 2016: Fuel shortage: Norwegian study Expands on Energy Problem in Chronic Fatigue Syndrome (ME/CFS) Fluge and Mella seem to be working at almost lightning speed. Besides managing their huge Rituximab study … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Fuel shortage: Norwegian study expands on energy problem in ME/CFS